Physician profile
Lane I Moore
NPI 1598723900
$9,357.28
in general payments reported to CMS, 2019-2025
25 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $6,903 · 2021: $193 · 2022: $1,078 · 2023: $242 · 2024: $338 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $6,641.91 | 2020 | |
| Globus Medical, INC. | $910.15 | 2022 | |
| Kerecis Limited | $241.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $200.41 | 2021-2024 | Plasmablade(Tm), Aquamantys(Tm) |
| Bioventus LLC | $196.29 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $176.15 | 2022-2024 | Variax |
| Organogenesis INC. | $157.38 | 2021 | |
| Integra Lifesciences Corporation | $154.84 | 2020 | |
| Sanara Medtech INC. | $143.77 | 2024-2025 | Celleraterx, Celleraterx |
| Nuvasive, INC. | $127.55 | 2019 | |
| Medtronic Vascular, INC. | $61.52 | 2020 | |
| Smith+Nephew, INC. | $59.98 | 2019 | |
| Davol INC. | $36.66 | 2024 | Phasix Mesh |
| Medtronic USA, INC. | $35.17 | 2019 | |
| Ethicon US, LLC | $29.99 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $24.58 | 2025 | |
| Braintree Laboratories, INC. | $23.84 | 2021 | |
| Biowound Solutions, INC. | $21.58 | 2025 | Bio-Connekt |
| Astrazeneca Pharmaceuticals LP | $20.23 | 2022 | |
| Tei Biosciences INC | $16.84 | 2019 | |
| Artivion, INC. | $16.49 | 2019 | |
| Teleflex LLC | $16.15 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.06 | 2019 | |
| Hologic Sales and Service, LLC | $14.85 | 2024 | Trunode, Trident Specimen Radiography System, Localizer |
| Tela Bio, INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lane Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.